Quadrant Capital Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $252K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $148K | Buy |
|
|||||
|
2024
Q4 | $57.9K | Sell |
|
|||||
|
2024
Q3 | $69K | Buy |
|
|||||
|
2024
Q2 | $55.9K | Sell |
|
|||||
|
2024
Q1 | $34.5K | Sell |
|
|||||
|
2023
Q4 | $58.6K | Buy |
|
|||||
|
2023
Q3 | $48.7K | Buy |
|
|||||
|
2023
Q2 | $47.9K | Sell |
|
|||||
|
2023
Q1 | $65.1K | Buy |
|
|||||
|
2022
Q4 | $72.7K | Sell |
|
|||||
|
2022
Q3 | $62K | Buy |
|
|||||
|
2022
Q2 | $44K | Buy |
|
|||||
|
2022
Q1 | $47K | Sell |
|
|||||
|
2021
Q4 | $60K | Sell |
|
|||||
|
2021
Q3 | $76K | Buy |
|
|||||
|
2021
Q2 | $62K | Buy |
|
|||||
|
2021
Q1 | $46K | Buy |
|
|||||
|
2020
Q4 | $33K | Sell |
|
|||||
|
2020
Q3 | $62K | Buy |
|
|||||
|
2020
Q2 | $28K | Sell |
|
|||||
|
2020
Q1 | $89K | Buy |
|
|||||
|
2019
Q4 | $90K | Buy |
|
|||||
|
2019
Q3 | $56K | Buy |
|
|||||
|
2019
Q2 | $30K | Sell |
|
|||||
|
2019
Q1 | $46K | Buy |
|
|||||
|
2018
Q4 | $5K | Sell |
|
|||||
|
2018
Q3 | $8K | Buy |
|
|||||
|
2018
Q2 | $7K | Sell |
|
|||||
|
2018
Q1 | $14K | Buy |
|
|||||
|
2017
Q4 | $10K | Hold |
|
|||||
|
2017
Q3 | $9K | Hold |
|
|||||
|
2017
Q2 | $6K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $7K | Hold |
|
|||||
|
2016
Q2 | $6K | Buy |
|
|||||
|
2016
Q1 | $0 | Sell |
|
|||||
|
2015
Q4 | $6K | Buy |
|